Results for 'Substitution'
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
Mar 12th • 7 mins read
Opportunities and challenges in biosimilar uptake in oncology
Jun 26th • 7 mins read